SRI Medicare Part D Conference to Spotlight Three Executives from the Managed Markets Practice at Campbell Alliance

October 13, 2006


Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotechnology industries, today announced that three executives in  its Managed Markets Practice will play prominent roles at the Strategic Research Institute’s (SRI) Medicare Part D Conference.  The event will be held from October 25-26 at the Doubletree Crystal City in Arlington, Virginia.


“This event is coming at an important time, as companies look to shape their Medicare strategies for 2007 and beyond.  In the coming months, pharmaceutical companies will begin analyzing the first full year’s worth of senior enrollment data since the inception of Medicare Part D to help guide their contacting and pricing strategies.  In addition, managed care organizations and pharmacy benefit managers will be conducting similar analyses to inform development of their bids to the Centers for Medicare and Medicaid Services next year.  Critical decisions made early next year will drive success in 2008,” stated Kevin Barnett, Senior Vice President and head of its Managed Markets Practice.


Mr. Barnett will present a session titled “Understanding and Addressing the Short- and Long-Term Implications of Medicare Part D” on October 25 at 9:15 a.m., which will address the critical decisions pharma marketers must make in the areas of brand management, account management, contracting, pricing, and field sales.


Also on October 25, at 1:15 p.m., Steve Carter, Senior Practice Executive, will moderate a roundtable discussion titled “Impact of Patient Sensitivity to Out-of-Pocket Costs on Pricing and Reimbursement Decisions.”  During this session, executives from CMS, Bristol-Myers Squibb, and Berlex will discuss how patient perceptions of out-of-pocket costs such as the “donut hole” might lead to a change in pricing and discount decisions by plans and manufacturers in subsequent years.


Lastly, Tony Lanzone, Senior Practice Executive, will present a session titled “Keys to Developing a Coordinated Channel Strategy for Managed Markets” on October 26 at 2:45 p.m.   The presentation will focus on identifying which managed markets channels (e.g., MCOs, PBMs, specialty pharmacy providers, long-term care facilities, hospitals and employers) are most important to manufacturers in order to position their products for success.


For more information on SRI’s Medicare conference, please visit 



About the Managed Markets Practice at Campbell Alliance


The Managed Markets Practice at Campbell Alliance has been helping clients identify and prepare for the implications of the MMA for the past three years.  Early on, the practice started working with clients in the pharmaceutical industry to anticipate what provisions the new Medicare legislation might contain and how such provisions could affect their businesses under various scenarios.  Campbell Alliance continues to help clients develop Medicare-related strategies at the corporate and product levels.  The firm helps clients tackle issues from pricing and contracting to marketing and selling.


About Campbell Alliance


Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industries.  The firm's clients include most of the world's "top 20" pharmaceutical companies, as well as numerous emerging and midsize firms.  Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, and Sales.  From its locations in Raleigh, N.C., Parsippany, N.J., Los Angeles, South San Francisco, Calif., Chicago, Boston, and New York City, the firm serves clients throughout North America, Europe, and Japan.  For more information on Campbell Alliance, please visit



inVentiv Health Consulting offers world class healthcare consulting services.

Media Contact:

Stephanie Koenig